Earlier this month, the Alliance for Integrity and Reform of 340B (“AIR340B”), a national advocacy group funded largely by pharmaceutical companies, released an update to their previous reports on charity…
On October 9, 2019, the White House issued two executive orders with potential implications on HRSA’s ability to enforce its sub-regulatory guidance, including its patient definition, against covered entities. In…
340B Health reports that Capt. Krista Pedley, the Director of OPA, stated last week at the Medicaid Drug Rebate Conference that OPA is reevaluating its enforcement of 340B program guidance…
In a Federal Register notice issued yesterday, CMS announced that it intends to survey hospitals on their acquisition costs for covered outpatient drugs purchased under the 340B program. CMS stated in the…
This week, the U.S District Court for the Southern District of Florida granted a motion for stay which paused the lawsuit between Sentry Data Systems Inc. and CVS Pharmacy after…
The Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting for November 13, 2019, 8:30…
This week, RWC-340B member Cempa Community Care was awarded the Times Free Press Champions of Health Care – Community Outreach Award. Cempa is located in Chattanooga, Tennessee and offers a…
In June 2018, Genesis Health Care, Inc., an FQHC in South Carolina, filed a lawsuit challenging its removal from the 340B program. HRSA removed Genesis from the 340B program following…
On July 9, 2019, HRSA issued an Information Collection Request (ICR) announcing that it would be embarking on a two year study entitled, “Assessing Care and Health Outcomes Among RWHAP…
On Thursday, July 25, 2019, the Senate Finance Committee voted to approve a wide-ranging drug pricing bill, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. The bill seeks to…